Logo image of CMN

CANTEL MEDICAL CORP (CMN) Stock Price, Quote, News and Overview

NYSE:CMN - New York Stock Exchange, Inc. - US1380981084

81.14  +0.62 (+0.77%)

After market: 81.14 0 (0%)

CMN Quote, Performance and Key Statistics

CANTEL MEDICAL CORP

NYSE:CMN (12/2/2016, 8:33:17 PM)

After market: 81.14 0 (0%)

81.14

+0.62 (+0.77%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High82.8
52 Week Low55.01
Market Cap3.38B
Shares41.70M
FloatN/A
Yearly Dividend0.14
Dividend Yield0.15%
PE56.35
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


CMN short term performance overview.The bars show the price performance of CMN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

CMN long term performance overview.The bars show the price performance of CMN in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20 25

The current stock price of CMN is 81.14 null. In the past month the price increased by 16.97%. In the past year, price increased by 25.06%.

CANTEL MEDICAL CORP / CMN Daily stock chart

About CMN

Company Profile

Cantel Medical Corp. is a healthcare company concentrating primarily in infection prevention and control products and diagnostic and therapeutic medical equipment. Through its United States subsidiary, MediVators, Inc., Cantel serves customers worldwide by designing, developing, manufacturing, marketing and distributing innovative products for the infection prevention and control industry.

Company Info

CANTEL MEDICAL CORP

150 CLOVE ROAD

LITTLE FALLS NJ 07424

CEO: Charles M. Diker

Phone: 973-890-7220

CANTEL MEDICAL CORP / CMN FAQ

What is the stock price of CANTEL MEDICAL CORP today?

The current stock price of CMN is 81.14 null. The price increased by 0.77% in the last trading session.


What is the ticker symbol for CANTEL MEDICAL CORP stock?

The exchange symbol of CANTEL MEDICAL CORP is CMN and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is CMN stock listed?

CMN stock is listed on the New York Stock Exchange, Inc. exchange.


What is CANTEL MEDICAL CORP worth?

CANTEL MEDICAL CORP (CMN) has a market capitalization of 3.38B null. This makes CMN a Mid Cap stock.


What are the support and resistance levels for CANTEL MEDICAL CORP (CMN) stock?

CANTEL MEDICAL CORP (CMN) has a support level at 77.51 and a resistance level at 81.87. Check the full technical report for a detailed analysis of CMN support and resistance levels.


Should I buy CANTEL MEDICAL CORP (CMN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CANTEL MEDICAL CORP (CMN) stock pay dividends?

CANTEL MEDICAL CORP (CMN) has a dividend yield of 0.15%. The yearly dividend amount is currently 0.14. Check the full fundamental report for a detailed analysis of CMN dividend history, reliability and sustainability.


What is the Price/Earnings (PE) ratio of CANTEL MEDICAL CORP (CMN)?

The PE ratio for CANTEL MEDICAL CORP (CMN) is 56.35. This is based on the reported non-GAAP earnings per share of 1.44 and the current share price of 81.14 null. Check the full fundamental report for a full analysis of the valuation metrics for CMN.


CMN Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to CMN. When comparing the yearly performance of all stocks, CMN is one of the better performing stocks in the market, outperforming 77.67% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CMN Financial Highlights

Over the last trailing twelve months CMN reported a non-GAAP Earnings per Share(EPS) of 1.44.


Industry RankSector Rank
PM (TTM) 104.9%
ROA 10.64%
ROE 16.7%
Debt/Equity 20.34
Chartmill High Growth Momentum
EPS Q2Q%-100%
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

CMN Ownership and Analysts


Ownership
Inst Owners82.99%
Ins Owners1.89%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y-100%
Revenue Next YearN/A